Epilepsy drug prevents brain tumors in mice with NF1
Researchers at Washington University School of Medicine have discovered that an FDA-approved epilepsy drug can prevent or slow the growth of NF1-linked optic gliomas in mice, laying the groundwork for a clinical trial.
Apte honored with macular degeneration award
Rajendra S. Apte, MD, PhD, the Paul A. Cibis Distinguished Professor and vice chair of innovation and translation in the John F. Hardesty, MD, Department of Ophthalmology & Visual Sciences at Washington University School of Medicine in St. Louis, has received the 2024 Roger H. Johnson Award.
Thompson named director of pediatric neurosurgery
Eric Thompson, MD, a pediatric neurosurgeon noted for his expertise in caring for children with complex neurological conditions, particularly brain and spinal tumors, has been named director of the Division of Pediatric Neurosurgery at Washington University School of Medicine in St. Louis and neurosurgeon-in-chief at St. Louis Children’s Hospital.
Ding receives Michelson Prize for advancing human immunology
Siyuan Ding, an assistant professor of molecular microbiology at Washington University School of Medicine in St. Louis, has received a Michelson Prize: Next Generation Grant from the Michelson Medical Research Foundation and the Human Immunome Project.
Naming Review Board at-large members named
Washington University in St. Louis leaders have selected the two at-large members of the newly created Naming Review Board. They are Steven Rosenblum, of University Advancement, and Russell Schwartz, an Arts & Sciences alumnus who works at the Starz television network.
AI-assisted breast-cancer screening may reduce unnecessary testing
In a recent study, researchers at Washington University School of Medicine in St. Louis and Whiterabbit.ai showed that artificial intelligence assistance potentially could improve breast-cancer screening by reducing the number of false positives without missing true positives.
How does a person’s mobility affect cardiovascular health?
A clinical trial led by researchers at Washington University School of Medicine in St. Louis is aimed at defining how exercise affects cardiovascular health in people who use wheelchairs.
Philip Needleman, emeritus trustee, longtime benefactor, 85
Philip Needleman, a Washington University in St. Louis emeritus trustee, longtime benefactor and former department head at the School of Medicine, died in an accident Monday, March 25, 2024, in Creve Coeur, Mo. He was 85.
Understanding how anxious misery affects brain networks aim of new grant
Janine Bijsterbosch, an assistant professor of radiology at the School of Medicine, is part of a team of five co-principal investigators studying how symptoms of depression, anxiety and stress — together known as anxious misery — affect functional brain networks. The team received a $3.6 million grant from the National Institute of Mental Health.
Combining multiple meds into a single pill reduces cardiovascular deaths
New research at the School of Medicine bolsters previous findings that “polypills” — single pills that combine medications that target cardiovascular disease-related conditions — are beneficial in preventing heart attacks and strokes and reducing deaths. As a result of the study, the World Health Organization has added such polypills to its most recent Model List of Essential Medicines.
View More Stories